Informazioni
Non ci sono recensioni
Immunology of Cutaneous Drug Eruptions
Pages 3-12
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Cutaneous Drug Eruptions
Diagnosis, Histopathology and Therapy
Hall, Hall
Editore
Springer
Anno
2015
Pagine
463
ISBN
9781447167280
140,00 €
The burden of cutaneous drug reactions is significant, in both outpatient and inpatient settings, and can result in morbidity and even mortality. This book is unique in its approach to this problem. This text is divided into basic principles, common drug reactions, skin conditions mimicked by drug reactions, drug reactions to the skin appendages, life-threatening drug reactions, less common drug reactions, and special groupings of drug reactions. For the clinician, the skin can only morphologically react in to many limited ways. This is also true for the pathologist. Combining these two forever linked specialties is a synergistic paradigm that greatly enhances diagnosis, and ultimately therapy, for these pernicious conditions. Drug reactions in the skin remain a common complication of therapy. True incidences of drug reactions are not available. For general discussion, the rule of 3% can be applied with reasonable assuredness. Approximately 3% of all hospitalized patients develop an adverse cutaneous drug reaction. Approximately 3% of these reactions are considered severe. Outpatient data is even more obscure, but at least 3% of dermatology clinic outpatient visits are due to a drug reaction. Cutaneous drug reactions compromise approximately 3% of all drug reactions. Even more challenging is the fact that the most vulnerable populations to drug reactions are increasing and include the elderly patients on prolonged drug therapy, and patients that use multiple drugs at the same time.
-
-
Principles of Diagnosis of Cutaneous Drug Eruptions
Pages 13-16
-
Histopathology of Drug Reactions
Pages 17-31
-
Principles of Treatment of Cutaneous Drug Eruptions
Pages 33-41
-
Morbilliform Drug Eruptions
Pages 45-53
-
Drug-Induced Urticaria
Pages 55-63
-
Erythema Multiforme and Drug Reactions
Pages 65-76
-
Drug-Induced Vasculitis
Pages 77-85
-
Pigment Changes and Drug Reactions
Pages 87-106
-
Drug-Induced Photosensitivity
Pages 107-121
-
Erythema Nodosum as a Drug Eruption
Pages 123-127
-
Lichen Planus Drug Reactions
Pages 129-134
-
Pityriasis Rosea-Like Drug Eruptions
Pages 135-140
-
Psoriasiform Drug Eruptions and Drugs That Flare Psoriasis
Pages 141-155
-
Acne and Drug Reactions
Pages 157-165
-
Collagen Vascular Diseases and Cutaneous Drug Reactions
Pages 167-180
-
Fixed Drug Eruptions
Pages 181-192
-
Autoimmune Bullous Diseases and Drugs
Pages 193-203
-
Lymphoma and Pseudolymphoma and Drug Reactions
Pages 205-211
-
Drug-Induced Alopecia
Pages 215-227
-
Drug Eruptions of the Scalp
Pages 229-234
-
Drug Reactions in the Nail in Cutaneous Drug Eruptions
Pages 235-247
-
Drug Eruptions and Erythroderma
Pages 251-258
-
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
Pages 259-269
-
Drug-Induced Delayed Multi-organ Hypersensitivity Syndrome
Pages 271-279
-
Acute Generalized Exanthematous Pustulosis
Pages 281-289
-
Cutaneous Drug Reactions to Anticoagulants
Pages 293-300
-
Antiepileptic Medications and Cutaneous Drug Reactions
Pages 301-308
-
Chemotherapy and Cutaneous Drug Reactions
Pages 309-321
-
Tyrosine Kinase Medications and the Skin
Pages 323-332
-
Medical Therapies and Their Effects on Skin Cancer
Pages 333-339
-
Cutaneous Reactions to BRAF Inhibitors
Pages 341-351
-
Cutaneous Reactions to Corticosteroids
Pages 353-359
-
Cutaneous Reactions to Retinoids
Pages 361-371
-
Neutrophilic Dermatoses
Pages 375-387
-
Granulomatous Drug Reactions
Pages 389-394
-
Cutaneous Drug Reactions in Patients Infected with Human Immunodeficiency Virus
Pages 397-430
-
Pediatric Drug Eruptions of the Skin
Pages 431-444
